Skip to main content

EXACT SCIENCES CORP (EXAS) Stock Forecast 2025 - AI Price Prediction & Analysis


EXACT SCIENCES CORP (EXAS) AI Stock Price Forecast & Investment Analysis

EXACT SCIENCES CORP Stock Price Chart and Technical Analysis

Loading EXACT SCIENCES CORP interactive price chart and technical analysis...

EXACT SCIENCES CORP (EXAS) - Comprehensive Stock Analysis & Investment Research

Deep dive into EXACT SCIENCES CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about EXACT SCIENCES CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For EXACT SCIENCES CORP: EXACT SCIENCES CORP operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

EXACT SCIENCES CORP (Stock Symbol: EXAS) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Medical Laboratories industry.

The organization employs approximately 5120 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing EXACT SCIENCES CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EXACT SCIENCES CORP: With $2939M in annual revenue and -8417.8% net margin, the company demonstrates developing profitability.

Annual Revenue: $2939 million generating a -8417.8% net profit margin .

Market Capitalization: $10485 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): -21.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for EXACT SCIENCES CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For EXACT SCIENCES CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for EXACT SCIENCES CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: EXACT SCIENCES CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For EXACT SCIENCES CORP: Market positioning analysis based on available financial and operational metrics.

EXACT SCIENCES CORP strategically competes in the highly dynamic Services-Medical Laboratories marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company maintains a healthy 16027.6% gross margin, indicating strong pricing power and operational efficiency.

EXACT SCIENCES CORP (EXAS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for EXACT SCIENCES CORP stock analysis.

Loading EXACT SCIENCES CORP comprehensive fundamental analysis and insider trading data...

Deep dive into EXACT SCIENCES CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if EXACT SCIENCES CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For EXACT SCIENCES CORP: With a P/E ratio of -343.62, the market sees the stock as potentially undervalued.

P/E Ratio -343.62x
P/B Ratio 4.25x
Market Cap $10485M
EPS $-5.45
Book Value/Share $13.05
Revenue/Share $15.54
FCF/Share $-0.63
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently EXACT SCIENCES CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For EXACT SCIENCES CORP: An ROE of -21.6% indicates room for improvement in shareholder value creation.

ROE -21.6%
ROA -11.3%
ROIC -12.6%
Gross Margin 16027.6%
Operating Margin -23184.7%
Net Margin -8417.8%
EBT Margin -40.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess EXACT SCIENCES CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For EXACT SCIENCES CORP: A current ratio of 2.53 indicates strong liquidity.

Current Ratio 2.53x
Quick Ratio 2.13x
D/E Ratio 0.72x
Financial Leverage 1.99x
Interest Coverage -58.0x
Working Capital $1623M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal EXACT SCIENCES CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For EXACT SCIENCES CORP: Free cash flow of $-355M indicates cash challenges that need attention.

Operating Cash Flow $-199M
Free Cash Flow $-355M
Capital Spending $-156M
FCF/Sales -19.2%
CapEx/Sales 8.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively EXACT SCIENCES CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For EXACT SCIENCES CORP: An asset turnover of 0.28x suggests room for improvement in asset utilization.

Asset Turnover 0.28x
Receivables Turnover 8.0x
Inventory Turnover 4.8x
Fixed Assets Turnover 2.6x
Days Sales Outstanding 46 days
Days Inventory 76 days
Payables Period 38 days
Cash Conversion Cycle 84 days
Understanding Financial Statement Data

What these metrics mean: Key figures from EXACT SCIENCES CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For EXACT SCIENCES CORP: With annual revenue of $2939M, EXACT SCIENCES CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2939M
R&D Expense $447M
SG&A Expense $87M
Cost of Goods Sold $-41M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 19%
Cash & Short-term Investments 13%
Total Liabilities 50%
Short-term Debt 5%
Accounts Receivable 3%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 189M
Growth Metrics (YoY)
EPS Growth -0.5%

Latest EXACT SCIENCES CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting EXACT SCIENCES CORP (EXAS) stock price and investment outlook.

, source: Insider Monkey

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth ...

EXACT SCIENCES CORP Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of EXACT SCIENCES CORP against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACON Unlock Forecast - 30 Days FREE Trial $3M 0.0x 1.2x
ACONW Unlock Forecast - 30 Days FREE Trial $0M x 0.2x
ADVB Unlock Forecast - 30 Days FREE Trial $9M x 2.2x
AMS Unlock Forecast - 30 Days FREE Trial $16M 5.2x 0.7x
BDSX Unlock Forecast - 30 Days FREE Trial $65M -3.0x 56.8x
BGLC Unlock Forecast - 30 Days FREE Trial $76M x 9.8x
BNR Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CAI Unlock Forecast - 30 Days FREE Trial $9388M 7.6x 20.7x
CDNA Unlock Forecast - 30 Days FREE Trial $757M 14.7x 2.3x
CELC Unlock Forecast - 30 Days FREE Trial $2545M -4.5x 57.4x
CSTL Unlock Forecast - 30 Days FREE Trial $683M -2110.5x 1.5x
DGX Unlock Forecast - 30 Days FREE Trial $20356M 21.4x 2.8x
EXAS Unlock Forecast - 30 Days FREE Trial $10485M -343.6x 4.3x
FLGT Unlock Forecast - 30 Days FREE Trial $680M 516.8x 0.6x
FTRE Unlock Forecast - 30 Days FREE Trial $909M -6.8x 1.5x
GH Unlock Forecast - 30 Days FREE Trial $7399M -8.9x -23.0x
GRAL Unlock Forecast - 30 Days FREE Trial $1277M x 0.6x
LH Unlock Forecast - 30 Days FREE Trial $23000M 30.1x 2.7x
NTRA Unlock Forecast - 30 Days FREE Trial $23220M -74.2x 18.6x
PMD Unlock Forecast - 30 Days FREE Trial $12M -5.7x 2.2x
PMDI Unlock Forecast - 30 Days FREE Trial $13M x 2.6x
PSNL Unlock Forecast - 30 Days FREE Trial $465M -2.3x 2.4x
RDNT Unlock Forecast - 30 Days FREE Trial $6939M 462.8x 7.4x
RENXF Unlock Forecast - 30 Days FREE Trial $10M x x
RNLXY Unlock Forecast - 30 Days FREE Trial $28M x x
SERA Unlock Forecast - 30 Days FREE Trial $152M -9.0x 1.7x
VCYT Unlock Forecast - 30 Days FREE Trial $2533M 96.2x 2.1x
XGN Unlock Forecast - 30 Days FREE Trial $213M -5.4x 10.1x

Frequently Asked Questions - EXACT SCIENCES CORP Stock Forecast

How accurate are EXACT SCIENCES CORP stock predictions?

Our AI model demonstrates 59% historical accuracy for EXAS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence EXACT SCIENCES CORP stock price forecasts?

Our analysis considers EXACT SCIENCES CORP's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is EXACT SCIENCES CORP a good investment in 2025?

Based on our AI analysis, EXACT SCIENCES CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are EXACT SCIENCES CORP forecasts updated?

EXACT SCIENCES CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced EXACT SCIENCES CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for EXACT SCIENCES CORP stock.

My Portfolio

Investment Dashboard

Loading your portfolio...